BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2423784)

  • 1. Indoramin in severe congestive heart failure.
    Grube E; Manz M; Lüderitz B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S117-23. PubMed ID: 2423784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarction.
    Silke B; Nelson GI; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S102-6. PubMed ID: 2423781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness].
    Grube E; Lauven GW; Manz M; Lüderitz B
    Dtsch Med Wochenschr; 1986 Mar; 111(11):416-20. PubMed ID: 3948703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
    De Kock MR; Detry JM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary observations of chronic indoramin therapy in congestive heart failure.
    Leier CV; Huss P; Parrish D; Binkley PF; Unverferth DV
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S112-6. PubMed ID: 2423783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity.
    Seth L; Galiè N; Casebolt P; Gimenez H; Malloy M; Franciosa JA
    Clin Pharmacol Ther; 1986 Nov; 40(5):567-74. PubMed ID: 3769387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic and hormonal response to indoramin in congestive heart failure.
    Olivari MT; Garberg VR; Selby T; Cohn JN; Levine TB
    Clin Pharmacol Ther; 1984 Sep; 36(3):297-301. PubMed ID: 6380878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
    Good AP; Unverferth DV; Leier CV
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
    Leier CV; Majetich N; Binkley PF; Uverferth DV
    Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial.
    Leier CV; Binkley PF; Randolph PH; Unverferth DV
    J Am Coll Cardiol; 1987 Feb; 9(2):426-32. PubMed ID: 3543093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
    Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; Berman D; Rahimtoola SH
    Am J Cardiol; 1983 Nov; 52(8):1041-5. PubMed ID: 6637820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic and hormonal effects of central versus peripheral sympathetic inhibition in patients with congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1986; 8(5):973-7. PubMed ID: 2429099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
    Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
    Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
    Zeng H; Sun L; Li W; Du J
    Chin Med J (Engl); 2000 Apr; 113(4):328-31. PubMed ID: 11775229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
    Sheridan DJ; Thomas P; Culling W; Collins P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.